Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLP - 1”

401 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 401 results

Not applicableStudy completedNCT02665715
What this trial is testing

Can Postprandial Reactive Hypoglycaemia be Reduced in Patients After Roux-en-Y Gastric Bypass With a Low Carbohydrate Diet?

Who this might be right for
Bariatric Surgery (Gastric Bypass)
Amirsalar Samkani 10
Large-scale testing (Phase 3)Study completedNCT01847313
What this trial is testing

The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Karl Neff 20
Post-approval studies (Phase 4)Study completedNCT02686177
What this trial is testing

Effect of GLP-1 on Angiogenesis

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 50
Not applicableLooking for participantsNCT07075341
What this trial is testing

Healthy Living BEYOND Weight Study

Who this might be right for
Overweight or Obesity
American Heart Association 1,000,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07221461
What this trial is testing

Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists

Who this might be right for
Wrinkle
Goldman, Butterwick, Fitzpatrick and Groff 24
Post-approval studies (Phase 4)Looking for participantsNCT06671587
What this trial is testing

IGlarLixi CGM Study in Chinese T2D Individuals After OADs

Who this might be right for
Type 2 Diabetes (T2D)
Sanofi 678
Large-scale testing (Phase 3)Study completedNCT05260021
What this trial is testing

Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

Who this might be right for
Type2 DiabetesDiabetes MellitusDiabetes Mellitus, Type 2+5 more
Eli Lilly and Company 99
Early research (Phase 1)Study completedNCT01456572
What this trial is testing

Gastric and Intestinal Satiation in Obese and Normal Weight Healthy People

Who this might be right for
Endocrine System Diseases
University Hospital, Basel, Switzerland 65
Not applicableStudy completedNCT01875575
What this trial is testing

Oral Glucose Stimulation in Normal-weight and Obese Volunteers

Who this might be right for
Endocrine System Diseases
University Hospital, Basel, Switzerland 24
Not applicableUnknownNCT02236299
What this trial is testing

Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting

Who this might be right for
Right Coronary Artery Percutaneous Coronary InterventionRight Ventricular Diastolic Dysfunction
Papworth Hospital NHS Foundation Trust 30
Post-approval studies (Phase 4)UnknownNCT04029272
What this trial is testing

Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients

Who this might be right for
Polycystic Ovary Syndrome
Peking Union Medical College Hospital 80
Not applicableStudy completedNCT03081676
What this trial is testing

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

Who this might be right for
Maturity-Onset Diabetes of the Young, Type 3
University Hospital, Gentofte, Copenhagen 20
Testing effectiveness (Phase 2)UnknownNCT05659368
What this trial is testing

Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1

Who this might be right for
Wolfram Syndrome
Ospedale San Raffaele 10
Post-approval studies (Phase 4)Study completedNCT06027567
What this trial is testing

The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure

Who this might be right for
Idiopathic Intracranial HypertensionIntracranial PressureObesity+3 more
Rigmor Højland Jensen 38
Not applicableStudy completedNCT02879955
What this trial is testing

Carbohydrates and Gut Hormones After Gastric Bypass Surgery

Who this might be right for
Overweight
Hvidovre University Hospital 20
Not applicableStudy completedNCT02385617
What this trial is testing

Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsWeight Loss+1 more
St. James's Hospital, Ireland 20
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Not applicableUnknownNCT02490176
What this trial is testing

Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters

Who this might be right for
Heart Failure
Chinese PLA General Hospital 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Large-scale testing (Phase 3)Study completedNCT01733758
What this trial is testing

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 494
Next Page